| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/19/2006 | CN1761753A Delta-endotoxin genes and methods for their use |
| 04/19/2006 | CN1761750A Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells |
| 04/19/2006 | CN1761749A Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 04/19/2006 | CN1761746A Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function |
| 04/19/2006 | CN1761744A Cultured CD14+ antigen presenting cells |
| 04/19/2006 | CN1761684A Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 04/19/2006 | CN1761683A Cancerous disease modifying antibodies |
| 04/19/2006 | CN1761682A Monoclonal antibody and hybridoma producing the same |
| 04/19/2006 | CN1761679A Peptide fragment of LYVE-1 and antibody against the same |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1761403A Method and compositions for improving animal health |
| 04/19/2006 | CN1760207A Method for obtaining antibody for anti immunoglobulin M of conspeciic animal, and method for detecting early infection by using the antibody |
| 04/19/2006 | CN1760206A Method for obtaining antibody of anti immunoglobulin in congeneric animal, and method for detecting infection of causes of disease by using the antibody |
| 04/19/2006 | CN1252473C Inhibitor-1 antibody of hepatic cell growth factor activator and its use |
| 04/19/2006 | CN1252264C Inhibition of viral infection using monovalent antigen-binding proteins |
| 04/19/2006 | CN1252257C Human G-type lysozyme and its coding sequence, preparing process and application |
| 04/19/2006 | CN1252085C Peptide as VEGF receptor KDR antagonist |
| 04/18/2006 | USRE39071 Anhydro-and isomer-a-21978c cyclic peptides |
| 04/18/2006 | US7030234 Non-M, non-O HIV-1 strains, fragments and uses |
| 04/18/2006 | US7030228 Monoclonal antibody for binding antigen, specific for an epitope of antigen; conjugated with radioactive isotops, fluorescents; immunotherapy for treating inflammation, autoimmune diseases |
| 04/18/2006 | US7030227 Cell regulatory genes, encoded products, and uses related thereto |
| 04/18/2006 | US7030226 Fc fusion proteins of human erythropoietin with increased biological activities |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029912 Nucleic acid; diagnosis, therapy of disease; cell transcription; genetic engineering |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/18/2006 | US7029890 Tyrosylprotein sulfotransferases and methods of use thereof |
| 04/18/2006 | US7029865 Nucleotide sequences coding G-protein coupled receptors (MC-4R) for treating obesity and eating disorders |
| 04/18/2006 | US7029864 Antibody against cleavage product of vimentin |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/18/2006 | US7029845 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses |
| 04/18/2006 | US7029682 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient |
| 04/18/2006 | US7029677 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 04/18/2006 | US7029676 Peptide composition for us e in the treatment of psoriasis |
| 04/18/2006 | US7029674 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | CA2252505C New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 04/13/2006 | WO2006039644A2 Methods of treating cd30 positive lymphomas |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006039173A2 Uses of an endothelial cell receptor |
| 04/13/2006 | WO2006039135A2 Irta-4 antibodies and their uses |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006037800A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE |
| 04/13/2006 | WO2006037604A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | WO2006037383A1 Piscirickettsia salmonis antigens and use thereof |
| 04/13/2006 | WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders |
| 04/13/2006 | WO2005112997A3 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues |
| 04/13/2006 | WO2005103698A3 Methods and antibodies for nitrofuran detection |
| 04/13/2006 | WO2005100405A3 Phosphorylcholine conjugates and corresponding antibodies |
| 04/13/2006 | WO2005080430A3 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations |
| 04/13/2006 | WO2005072479A3 Polymer-bound antibody concer therapeutic agent |
| 04/13/2006 | WO2005035575A3 Humanization of antibodies |
| 04/13/2006 | WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/13/2006 | WO2005026377A3 Detection of nucleic acid sequences |
| 04/13/2006 | WO2005013090A3 Systems and methods for biopolymer engineering |
| 04/13/2006 | US20060080745 Gene reactivation by somatic hypermutation |
| 04/13/2006 | US20060079674 Contraceptive targets |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079580 Production of mutant strain of aspergillus fumigatus, method of assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection |
| 04/13/2006 | US20060079470 Combined dna vaccine and biological modifiers for cancer therapy |
| 04/13/2006 | US20060079457 BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 04/13/2006 | US20060078991 host cells into which a gene encoding an antibody is introduced, which is resistant to a section which recognizes a sugar chain in which fucose is bound to N-acetylglucosamine in a complex N-glycoside-linked sugar chain; antibodies used for diseases having antibody-dependent cell-mediated cytotoxicity |
| 04/13/2006 | US20060078990 antibodies comprising complex N-glycoside-linked sugar chains bound to the Fc fragments, having reduced levels of fucose bound to N-acetylglucosamine; antibodies with increased antibody-dependent cellular cytotoxicity; fusion proteins |
| 04/13/2006 | US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078964 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/13/2006 | US20060078957 A host cell containing an expression vector for an aggrecanase to use as a drug screening agent for joint diseases |
| 04/13/2006 | US20060078953 Epad, an oocyte specific protein |
| 04/13/2006 | US20060078951 Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody |
| 04/13/2006 | US20060078946 Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody |
| 04/13/2006 | US20060078945 Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H |
| 04/13/2006 | US20060078943 Method for obtaining anti-idiotype antibodies |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078912 Methods and compositions for the detection of biological molecules using a two particle complex |
| 04/13/2006 | US20060078909 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078559 Detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity using a heme binding protein (HBP) polypeptide as a modulating agents of polypeptide activity;. antibodies against FPRL2; drug screening for treating diseases characterized by dysregulation of FPRL2 polypeptide signal transduction |
| 04/13/2006 | US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases |
| 04/13/2006 | US20060078557 Methods and compositions for promoting immunopotentiation |
| 04/13/2006 | US20060078556 Antibodies and epitopes specific to tRNA synthetase fragments |
| 04/13/2006 | US20060078550 Porcine fgl2 |
| 04/13/2006 | US20060078539 Remedies for tumor in hematopoietic organs |
| 04/13/2006 | US20060078537 Mono-and dual chemokine/cytokine constructs |
| 04/13/2006 | US20060078490 Synthesis of water soluble nanocrystalline quantum dots and uses thereof |
| 04/13/2006 | CA2615139A1 Piscirickettsia salmonis antigens and use thereof |
| 04/13/2006 | CA2583431A1 Variant amyloid protein |
| 04/13/2006 | CA2583417A1 Antagonists and methods of use therefor |
| 04/13/2006 | CA2583061A1 Antibody production method |
| 04/13/2006 | CA2582683A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | CA2582016A1 Methods of treating cd30 positive lymphomas |
| 04/13/2006 | CA2580967A1 Irta-4 antibodies and their uses |
| 04/12/2006 | EP1645631A2 Neisseria antigens and compositions |
| 04/12/2006 | EP1645629A1 Human osteoclast-specific and related genes |
| 04/12/2006 | EP1645567A1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 04/12/2006 | EP1645292A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645291A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645290A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |